RT Journal Article
SR Electronic
T1 The phase angle is associated with upper arm muscle circumference but not with sarcopenia in continuous ambulatory peritoneal dialysis patients
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.07.10.22277470
DO 10.1101/2022.07.10.22277470
A1 Chen, Ye
A1 Wu, Jinlan
A1 Ran, Lei
A1 Yu, Dan
A1 Chen, Xi
A1 Liu, Maodong
YR 2022
UL http://medrxiv.org/content/early/2022/07/11/2022.07.10.22277470.abstract
AB Aims Limited studies on phase angle (PhA) and sarcopenia in continuous ambulatory peritoneal dialysis (CAPD) patients. We want to explore the association between PhA and sarcopenia and clarify its significance and value in diagnosing sarcopenia.Methods We included 87 CAPD patients. We measured the PhA and body composition by bioelectrical impedance analysis. All patients had their handgrip strength(HGS) measured. Then, we divided patients into the sarcopenia (n=25) group and non-sarcopenia(n=62) group according to the sarcopenia diagnostic strategy formulated by the Asian Working Group for Sarcopenia.Results Univariate analysis shows PhA is positively associated with HGS, skeletal muscle mass (SMM), and Upper arm muscle circumference (AMC). After adjustments for sex, age, diabetes, BMI, extracellular water ratio(E/T), extra water (OH), serum creatinine, total kt/v, and residual kt/v, PhA remains correlated to HGS and AMC, but not to SMM. In the multivariate logistic model, PhA is not correlated to sarcopenia. The AUROC of PhA for sarcopenia is 0.76(95% CI, 0.65-0.86, P <0.01, fig 3). The optimal cut-off value is identified as ≤5.25(sensitivity 74%, specificity 76%).Conclusion This study illustrates that older age and higher total kt/v are risk factors for sarcopenia. PhA is positively associated with HGS and AMC but not with sarcopenia in CAPD patients. These results suggest that PhA can predict muscle mass and strength in CAPD patients, but its diagnosis value for sarcopenia needs more studies.Competing Interest StatementThe authors have declared no competing interest.Funding StatementYES-This study was funded by The government subsidizing the training program for outstanding clinical medical talents in 2021, study on nutrition evaluation and intervention of chronic kidney disease population- based on machine learning(103), Hebei Provincial Health Commission. It Provides funding for following up patients and finding papers .Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Ethics Committee approved the study protocol of The Third Hospital of Hebei Medical University (number:20210931). All subjects signed an informed consent form.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll relevant data are within the manuscript and its Supporting Information files.